2005
DOI: 10.5414/cnp64343
|View full text |Cite
|
Sign up to set email alerts
|

Oxidative stress and non-enzymatic glycation in IgA nephropathy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
8
0

Year Published

2007
2007
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(8 citation statements)
references
References 0 publications
0
8
0
Order By: Relevance
“…IgA nephropathy (IgAN), the most common glomerular disease globally, is a leading cause of CKD and renal failure. A systemic pro-oxidant environment—marked by increased serum levels of lipoperoxide or malondialdehyde and reduced activity of superoxide dismutase, catalase, and glutathione peroxidase, as detected in sera of patients with IgAN—has been associated with disease activity and progression [131,132,133]. Markedly, circulating AOPP have been shown to correlate with proteinuria and be a potent risk marker of decline in the renal function and disease progression since early in the clinical course of IgAN.…”
Section: Oxidative Stress and Clinical Models Of Ckdmentioning
confidence: 99%
“…IgA nephropathy (IgAN), the most common glomerular disease globally, is a leading cause of CKD and renal failure. A systemic pro-oxidant environment—marked by increased serum levels of lipoperoxide or malondialdehyde and reduced activity of superoxide dismutase, catalase, and glutathione peroxidase, as detected in sera of patients with IgAN—has been associated with disease activity and progression [131,132,133]. Markedly, circulating AOPP have been shown to correlate with proteinuria and be a potent risk marker of decline in the renal function and disease progression since early in the clinical course of IgAN.…”
Section: Oxidative Stress and Clinical Models Of Ckdmentioning
confidence: 99%
“…These complexes stimulate cultured human mesangial cells (3)(4)(5), resulting in activation of oxidative stress pathways (6 -8). Evidence of increased oxidative stress has been noted in renal tissue of patients with IgAN (9) as well as in their sera and/or erythrocytes (i.e., increased levels of lipoperoxide or malondialdehyde and reduced activity of superoxide dismutase, catalase, and glutathione peroxidase) (10,11). Moreover, increased serum levels of another marker of oxidative stress, advanced oxidation protein products (AOPPs), have been recently associated with proteinuria and disease progression in patients with IgAN (12).…”
Section: Introductionmentioning
confidence: 99%
“…Markers of oxidative stress, including increased levels of lipoperoxide or malondialdehyde and reduced activity of superoxide dismutase, catalase and glutathione peroxidase enzymes, have been shown in kidney tissue of patients with IgAN [12]. Similar findings were also described in serum and/or red blood cells of patients with IgAN [13,14]. Additionally, elevated levels of oxidative stress markers, advanced oxidation protein products (AOPPs), have been reported to be associated with proteinuria and disease progression in IgAN patients [15,16].…”
Section: Introductionmentioning
confidence: 66%